Jump to ContentJump to Main Navigation

Online

149,00 € / $224.00*

* Prices subject to change. Shipping costs will be added if applicable.
Publication Date:
December 2011
ISSN:
2191-0251
DOI:
10.1515/jpem.2011.371

See all formats and pricing

Online
Individual Subscription Online only
Euro [D] 149.00
RRP for USA, Canada, Mexico
US$ 224.00 *
Print
Individual Subscription Online only
Euro [D] 873.00
RRP for USA, Canada, Mexico
US$ 1310.00 *
Print + Online
Individual Subscription Online only
Euro [D] 1048.00
RRP for USA, Canada, Mexico
US$ 1572.00 *
*Prices subject to change. Shipping costs will be added if applicable.

Editor-in-Chief: Zadik, Zvi

Editorial Board Member: Cassorla, Fernando / Cutfield, Wayne / de Muinck Keizer-Schrama, Sabine M.P.F. / Fideleff, Hugo L. / LaFranch, Stephen H. / Lanes M. D., Roberto / Levitsky, Lynne / Lippe, Barbara / Pfäffle, Roland / Root, Allen W. / Rosenfeld, Ron G. / Werther, George / Kiess, Wieland

12 Issues per year

IMPACT FACTOR 2011: 0.875
5-year IMPACT FACTOR: 1.026

VolumeIssuePage

Issues

Lack of mutations in the gene coding for the hGR (NR3C1) in a pediatric patient with ACTH-secreting pituitary adenoma, absence of stigmata of Cushing's syndrome and unusual histologic features

George Briassoulis1, 2, 5 / Anelia Horvath1 / Paola Christoforou1 / Maya Lodish1, 2 / Paraskevi Xekouki1 / Martha Quezado3 / Nicholas Patronas4 / Meg F. Keil1, 2 / 1, 2

1Section on Endocrinology and Genetics, Program on Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, MD 20892, USA

2Pediatric Endocrinology, Inter-Institute Training Program, National Institutes of Health (NIH), Bethesda, MD 20892, USA

3Laboratory of Pathology, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD 20892, USA

4Department of Diagnostic Radiology, Clinical Research Center, National Institutes of Health (NIH), Bethesda, MD 20892, USA

5Pediatric Intensive Care Unit, University Hospital of Heraklion, P.O. Box 1352, 71110 Heraklion, Crete, Greece

Corresponding author: Constantine A. Stratakis, MD, D(Med)Sc, Scientific Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Chief, Section on Endocrinology and Genetics (SEGEN), PDEGEN, NICHD, and Director, Inter-Institute Pediatric Endocrinology Program, NIH, Building 10, CRC, Room 1-3330, 10 Center, Bethesda, MD 20892, USA Phone: +301-496-4686/496-6683, Fax: +301-402-0574/480-0378

Citation Information: Journal of Pediatric Endocrinology and Metabolism. Volume 25, Issue 1-2, Pages 213–219, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: 10.1515/jpem.2011.371, December 2011

Publication History:
Received:
2011-07-31
Accepted:
2011-11-15
Published Online:
2011-12-20

Abstract

Background: Rare cases of human glucocorticoid receptor (hGRα) (NR3C1) gene mutations have been described in the gemline or somatic state in Cushing’s disease (CD).

Aim: We describe a pediatric patient with CD with clinical evidence of partial glucocorticoid resistance (GR) due to the relative absence of stigmata of Cushing’s syndrome (CS).

Case description: A 14-year-old boy with slow growth and hypertension, but no other signs of CS was admitted for CD evaluation. Urinary free cortisol levels (UFC) were consistently 2-3-fold the upper normal range. Pituitary magnetic resonance imaging (MRI) revealed a 3×4 mm hypoenhancing lesion in the right side of the pituitary gland anteriorly (microadenoma). A graded dexamethasone suppression test indicated that the patient had partial GR. Histology confirmed an adrenocorticotrophin (ACTH)-producing pituitary adenoma. We hypothesized that a NR3C1 mutation was present. Sequencing of the entire coding region of the gene produced normal results in both peripheral and tumor DNA.

Conclusion: We present the case of a pediatric patient with an ACTH-producing tumor but little evidence of CS. No mutations in the coding sequence of NR3C1 were detected. We conclude that low level somatic mosaicism for NR3C1 mutations or a mutation in another molecule participating in hGRα-signaling may account for this case.

Keywords: cortisol resistance; Cushing’s disease; pituitary tumors

Comments (0)

Please log in or register to comment.